Suchergebnisse

Frontmatter -- CONTENTS -- Acknowledgments -- About the Editors and Contributors -- Introduction -- PART I: THE NATURE OF THE PROBLEM AND THE RESPONSE -- 1. The Political Economy of Terrorism Financing -- 2. Terrorism Financing Mechanisms and Policy Dilemmas -- 3. Organized Crime and Terrorism -- 4. Terrorist Organizations' Vulnerabilities and Inefficiencies: A Rational Choice Perspective -- 5. Warning Indicators and Terrorist Finances -- PART II: CASE STUDIES OF TERRORISM FINANCING AND STATE RESPONSES -- 6. Financing Afghan Terrorism: Thugs, Drugs, and Creative Movements of Money -- 7. Al Qaeda Finances and Funding to Affiliated Groups -- 8. Hezbollah Finances: Funding the Party of God -- 9. Arab Government Responses to the Threat of Terrorist Financing -- 10. Terrorism Financing in Europe -- 11. Terrorist Financing and Government Responses in East Africa -- 12. Terrorist Financing and Government Responses in Southeast Asia -- 13. Terrorist Financing and the Tri-Border Area of South America: The Challenge of Effective Governmental Response in a Permissive Environment -- 14. Anti-Terror Strategy, The 9/11 Commission Report, and Terrorism Financing: Implications for U.S. Policy Makers -- 15. U.S. and International Responses to Terrorist Financing -- 16. Terrorist Financing: Explaining Government Responses -- Notes -- Index

Widespread acceptance of COVID-19 vaccines is crucial for achieving sufficient immunization coverage to end the global pandemic, yet few studies have investigated COVID-19 vaccination attitudes in lower-income countries, where large-scale vaccination is just beginning. We analyze COVID-19 vaccine acceptance across 15 survey samples covering 10 low- and middle-income countries (LMICs) in Asia, Africa and South America, Russia (an upper-middle-income country) and the United States, including a total of 44,260 individuals. We find considerably higher willingness to take a COVID-19 vaccine in our LMIC samples (mean 80.3%; median 78%; range 30.1 percentage points) compared with the United States (mean 64.6%) and Russia (mean 30.4%). Vaccine acceptance in LMICs is primarily explained by an interest in personal protection against COVID-19, while concern about side effects is the most common reason for hesitancy. Health workers are the most trusted sources of guidance about COVID-19 vaccines. Evidence from this sample of LMICs suggests that prioritizing vaccine distribution to the Global South should yield high returns in advancing global immunization coverage. Vaccination campaigns should focus on translating the high levels of stated acceptance into actual uptake. Messages highlighting vaccine efficacy and safety, delivered by healthcare workers, could be effective for addressing any remaining hesitancy in the analyzed LMICs.